Olema Pharmaceuticals, Inc. (OLMA)
7.20
-0.16
(-2.17%)
USD |
NASDAQ |
Oct 13, 09:42
Olema Pharmaceuticals Price : 7.20 for Oct. 13, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 12, 2026 | 7.77 | 7.77 | 7.33 | 7.36 | 1.019M |
| Oct 09, 2026 | 7.77 | 8.00 | 7.725 | 7.82 | 758251.0 |
| Oct 08, 2026 | 7.87 | 8.21 | 7.56 | 7.82 | 1.400M |
| Oct 07, 2026 | 7.90 | 8.23 | 7.79 | 7.94 | 819455.0 |
| Oct 06, 2026 | 8.28 | 8.29 | 7.80 | 7.92 | 1.039M |
| Oct 05, 2026 | 8.28 | 8.30 | 7.85 | 8.25 | 1.006M |
| Oct 02, 2026 | 8.39 | 8.52 | 8.10 | 8.225 | 1.072M |
| Oct 01, 2026 | 8.58 | 8.66 | 8.19 | 8.27 | 1.010M |
| Sep 30, 2026 | 8.59 | 8.86 | 8.42 | 8.64 | 1.543M |
| Sep 29, 2026 | 8.60 | 8.73 | 8.46 | 8.54 | 1.081M |
| Sep 28, 2026 | 8.71 | 8.85 | 8.40 | 8.61 | 979229.0 |
| Sep 25, 2026 | 9.04 | 9.04 | 8.57 | 8.75 | 1.383M |
| Sep 24, 2026 | 8.79 | 9.27 | 8.59 | 9.04 | 1.486M |
| Sep 23, 2026 | 9.64 | 9.64 | 8.70 | 8.83 | 1.642M |
| Sep 22, 2026 | 9.66 | 9.815 | 9.56 | 9.64 | 1.491M |
| Sep 21, 2026 | 9.95 | 10.13 | 9.61 | 9.63 | 1.070M |
| Sep 18, 2026 | 9.88 | 9.93 | 9.75 | 9.82 | 3.061M |
| Sep 17, 2026 | 9.89 | 10.35 | 9.73 | 9.90 | 1.088M |
| Sep 16, 2026 | 9.86 | 9.93 | 9.44 | 9.73 | 1.248M |
| Sep 15, 2026 | 10.29 | 10.34 | 9.65 | 9.78 | 1.733M |
| Sep 14, 2026 | 9.99 | 10.37 | 9.79 | 10.29 | 1.823M |
| Sep 11, 2026 | 10.79 | 10.86 | 10.18 | 10.22 | 1.013M |
| Sep 10, 2026 | 10.19 | 10.98 | 10.11 | 10.69 | 1.116M |
| Sep 09, 2026 | 11.13 | 11.18 | 10.35 | 10.36 | 863843.0 |
| Sep 08, 2026 | 10.61 | 11.06 | 10.46 | 10.98 | 736717.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| SELLAS Life Sciences Group, Inc. | 11.96 |
| ACADIA Pharmaceuticals, Inc. | 18.85 |
| Alnylam Pharmaceuticals, Inc. | 226.00 |
| Anika Therapeutics, Inc. | 20.47 |
| Savara, Inc. | 4.87 |
Price Related Metrics
| PEG Ratio | -0.3347 |
| Price to Book Value | 1.462 |
| Earnings Yield | -29.42% |
| Market Cap | 629.66M |
| PEGY Ratio | -0.3347 |